Tower Research Capital LLC (Trc) Legend Biotech Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Legend Biotech Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 984 shares of LEGN stock, worth $39,114. This represents 0.0% of its overall portfolio holdings.
Number of Shares
984
Previous 247
298.38%
Holding current value
$39,114
Previous $10,000
370.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$444 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$298 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$264 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$227 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$200 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.65B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...